LONA
LeonaBio, Inc.
+0.11 (+1.62%)6.90USD4.1K成交股數65.0M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-08-06下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 03-05 | Worthington Mark | GENERAL COUNSEL and CCO | S 公開市場賣出 | 1.3K | 5.37 | 7K | 18.4K | SEC |
| 2026-03-04 | 03-05 | Litton Mark James | PRESIDENT and CEO | S 公開市場賣出 | 5.2K | 5.37 | 28K | 57.9K | SEC |
| 2026-03-04 | 03-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 1.4K | 5.37 | 7K | 25.2K | SEC |
| 2026-03-04 | 03-05 | Renninger Robert | CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 906 | 5.37 | 5K | 15.9K | SEC |
| 2026-03-04 | 03-05 | San Martin Javier | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 1.7K | 5.37 | 9K | 15.9K | SEC |
| 2026-03-03 | 03-05 | Renninger Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 3.9K | – | – | 16.8K | SEC |
| 2026-03-03 | 03-05 | Litton Mark James | PRESIDENT and CEO | M 選擇權執行 | 22.3K | – | – | 63.1K | SEC |
| 2026-03-03 | 03-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 5.9K | – | – | 26.5K | SEC |
| 2026-03-03 | 03-05 | San Martin Javier | CHIEF MEDICAL OFFICER | M 選擇權執行 | 7.4K | – | – | 17.6K | SEC |
| 2026-03-03 | 03-05 | Worthington Mark | GENERAL COUNSEL and CCO | M 選擇權執行 | 5.7K | – | – | 19.7K | SEC |
| 2026-01-02 | 01-05 | Litton Mark James | President and CEO | S 公開市場賣出 | 2.6K | 6.88 | 18K | 40.8K | SEC |
| 2026-01-02 | 01-05 | Renninger Robert | Chief Financial Officer | S 公開市場賣出 | 297 | 6.88 | 2K | 12.9K | SEC |
| 2026-01-02 | 01-05 | Worthington Mark | General Counsel and CCO | S 公開市場賣出 | 876 | 6.88 | 6K | 14.0K | SEC |
| 2026-01-02 | 01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 876 | 6.88 | 6K | 20.7K | SEC |
| 2026-01-02 | 01-05 | San Martin Javier | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 1.6K | 6.88 | 11K | 10.2K | SEC |
| 2025-12-31 | 01-05 | Litton Mark James | President and CEO | M 選擇權執行 | 10.8K | – | – | 43.4K | SEC |
| 2025-12-31 | 01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 3.7K | – | – | 21.6K | SEC |
| 2025-12-31 | 01-05 | Renninger Robert | Chief Financial Officer | M 選擇權執行 | 1.2K | – | – | 13.2K | SEC |
| 2025-12-31 | 01-05 | Worthington Mark | General Counsel and CCO | M 選擇權執行 | 3.7K | – | – | 14.9K | SEC |
| 2025-12-31 | 01-05 | San Martin Javier | CHIEF MEDICAL OFFICER | M 選擇權執行 | 4.7K | – | – | 11.8K | SEC |
| 2025-12-23 | 12-23 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director,TenPercentOwner | A 獲配股票 | 330K | 6.35 | 2.1M | 330K | SEC |
| 2025-12-23 | 12-23 | EDELMAN JOSEPH | Director,TenPercentOwner | A 獲配股票 | 330K | 6.35 | 2.1M | 330K | SEC |
| 2025-12-23 | 12-23 | Perceptive Xontogeny Venture Fund II, LP | Director,TenPercentOwner | A 獲配股票 | 989K | 6.35 | 6.3M | 1.5M | SEC |
| 2025-12-23 | 12-23 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director,TenPercentOwner | A 獲配股票 | 989K | 6.35 | 6.3M | 1.5M | SEC |
| 2025-12-23 | 12-23 | PERCEPTIVE ADVISORS LLC | Director,TenPercentOwner | A 獲配股票 | 989K | 6.35 | 6.3M | 1.5M | SEC |
| 2025-12-23 | 12-23 | PERCEPTIVE ADVISORS LLC | Director,TenPercentOwner | A 獲配股票 | 330K | 6.35 | 2.1M | 330K | SEC |
| 2025-12-23 | 12-23 | EDELMAN JOSEPH | Director,TenPercentOwner | A 獲配股票 | 989K | 6.35 | 6.3M | 1.5M | SEC |
| 2025-12-23 | 12-23 | Perceptive Xontogeny Venture Fund II, LP | Director,TenPercentOwner | A 獲配股票 | 330K | 6.35 | 2.1M | 330K | SEC |
| 2025-11-18 | 01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 1.0K | 2.31 | 2K | 17.9K | SEC |
| 2025-11-18 | 01-05 | Renninger Robert | Chief Financial Officer | A 獲配股票 | 1.0K | 2.31 | 2K | 11.9K | SEC |
| 2025-07-01 | 07-02 | Worthington Mark | General Counsel and CCO | S 公開市場賣出 | 8.5K | 0.29 | 2K | 112K | SEC |
| 2025-07-01 | 07-02 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 8.5K | 0.29 | 2K | 169K | SEC |
| 2025-07-01 | 07-02 | Litton Mark James | President and CEO | S 公開市場賣出 | 25.1K | 0.29 | 7K | 326K | SEC |
| 2025-07-01 | 07-02 | San Martin Javier | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 10.8K | 0.29 | 3K | 71.7K | SEC |
| 2025-07-01 | 07-02 | Renninger Robert | SVP, Finance and Accounting | S 公開市場賣出 | 2.9K | 0.29 | 840.13 | 109K | SEC |
| 2025-06-30 | 07-02 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 36.7K | – | – | 177K | SEC |
| 2025-06-30 | 07-02 | Renninger Robert | SVP, Finance and Accounting | M 選擇權執行 | 12.4K | – | – | 112K | SEC |
| 2025-06-30 | 07-02 | Litton Mark James | President and CEO | M 選擇權執行 | 108K | – | – | 351K | SEC |
| 2025-06-30 | 07-02 | San Martin Javier | CHIEF MEDICAL OFFICER | M 選擇權執行 | 46.7K | – | – | 82.5K | SEC |
| 2025-06-30 | 07-02 | Worthington Mark | General Counsel and CCO | M 選擇權執行 | 36.7K | – | – | 120K | SEC |
| 2025-05-19 | 07-02 | Renninger Robert | SVP, Finance and Accounting | A 獲配股票 | 10.0K | 0.23 | 2K | 99.7K | SEC |
| 2025-05-19 | 07-02 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 10.0K | 0.23 | 2K | 141K | SEC |
| 2025-01-02 | 01-03 | San Martin Javier | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 10.8K | 0.56 | 6K | 35.8K | SEC |
| 2025-01-02 | 01-03 | Litton Mark James | President and CEO | S 公開市場賣出 | 25.1K | 0.56 | 14K | 243K | SEC |
| 2025-01-02 | 01-03 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 8.5K | 0.56 | 5K | 131K | SEC |
| 2025-01-02 | 01-03 | Renninger Robert | VP of Finance | S 公開市場賣出 | 2.9K | 0.56 | 2K | 89.7K | SEC |
| 2025-01-02 | 01-03 | Worthington Mark | General Counsel and CCO | S 公開市場賣出 | 8.5K | 0.56 | 5K | 83.7K | SEC |
| 2024-12-31 | 01-03 | San Martin Javier | CHIEF MEDICAL OFFICER | M 選擇權執行 | 46.7K | – | – | 46.7K | SEC |
| 2024-12-31 | 01-03 | Litton Mark James | President and CEO | M 選擇權執行 | 108K | – | – | 268K | SEC |
| 2024-12-31 | 01-03 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 36.7K | – | – | 139K | SEC |
| 2024-12-31 | 01-03 | Renninger Robert | VP of Finance | M 選擇權執行 | 12.4K | – | – | 92.6K | SEC |
| 2024-12-31 | 01-03 | Worthington Mark | General Counsel and CCO | M 選擇權執行 | 36.7K | – | – | 92.2K | SEC |
| 2024-11-18 | 01-03 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 9.9K | 0.55 | 5K | 103K | SEC |
| 2024-11-18 | 01-03 | Worthington Mark | General Counsel and CCO | A 獲配股票 | 3.7K | 0.55 | 2K | 55.6K | SEC |
| 2024-11-18 | 01-03 | Renninger Robert | VP of Finance | A 獲配股票 | 3.7K | 0.55 | 2K | 80.2K | SEC |
| 2024-09-05 | 09-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 2.5K | 0.57 | 1K | 92.7K | SEC |
| 2024-09-05 | 09-05 | Worthington Mark | GENERAL COUNSEL | S 公開市場賣出 | 2.5K | 0.57 | 1K | 51.9K | SEC |
| 2024-09-05 | 09-05 | Litton Mark James | President and CEO | S 公開市場賣出 | 5.0K | 0.57 | 3K | 159K | SEC |
| 2024-09-05 | 09-05 | Gengos Andrew | CFO and Chief Business Officer | S 公開市場賣出 | 1.3K | 0.57 | 725.04 | 97.5K | SEC |
| 2024-09-05 | 09-05 | Lenington Rachel | COO and CDO | S 公開市場賣出 | 2.5K | 0.57 | 1K | 20.9K | SEC |
| 2024-09-03 | 09-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 10.0K | – | – | 95.2K | SEC |
| 2024-09-03 | 09-05 | Worthington Mark | GENERAL COUNSEL | A 獲配股票 | 10.0K | – | – | 54.5K | SEC |
| 2024-09-03 | 09-05 | Litton Mark James | President and CEO | A 獲配股票 | 20.0K | – | – | 164K | SEC |
| 2024-09-03 | 09-05 | Lenington Rachel | COO and CDO | A 獲配股票 | 10.0K | – | – | 23.4K | SEC |
| 2024-09-03 | 09-05 | Gengos Andrew | CFO and Chief Business Officer | A 獲配股票 | 5.0K | – | – | 98.8K | SEC |
| 2024-06-24 | 06-25 | Romano Kelly A | Director | P 公開市場買進 | 27.4K | 2.42 | 66K | 80.7K | SEC |
| 2024-06-21 | 06-25 | Romano Kelly A | Director | P 公開市場買進 | 15.0K | 2.26 | 34K | 53.3K | SEC |
| 2024-05-20 | 09-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 5.0K | 1.34 | 7K | 85.2K | SEC |
| 2024-05-20 | 09-05 | Gengos Andrew | CFO and Chief Business Officer | A 獲配股票 | 10.0K | 1.34 | 13K | 93.8K | SEC |
| 2024-05-20 | 09-05 | Worthington Mark | GENERAL COUNSEL | A 獲配股票 | 10.0K | 1.34 | 13K | 44.5K | SEC |
| 2024-01-05 | 02-16 | Litton Mark James | CEO | S 公開市場賣出 | 4.8K | 2.91 | 14K | 144K | SEC |
| 2024-01-05 | 02-16 | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | S 公開市場賣出 | 1.2K | 2.91 | 4K | 83.8K | SEC |
| 2024-01-05 | 02-16 | Lenington Rachel | COO AND CDO | S 公開市場賣出 | 2.4K | 2.91 | 7K | 13.4K | SEC |
| 2024-01-05 | 02-16 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 2.4K | 2.91 | 7K | 80.3K | SEC |
| 2024-01-05 | 02-16 | Worthington Mark | GENERAL COUNSEL | S 公開市場賣出 | 2.4K | 2.91 | 7K | 34.5K | SEC |
| 2024-01-05 | 01-08 | Litton Mark James | Chief Executive Officer | S 公開市場賣出 | 4.8K | 2.91 | 14K | 144K | SEC |
| 2024-01-05 | 01-08 | Lenington Rachel | Chief Operating Officer | S 公開市場賣出 | 2.4K | 2.91 | 7K | 13.4K | SEC |
| 2024-01-05 | 01-08 | Worthington Mark | General Counsel | S 公開市場賣出 | 2.4K | 2.91 | 7K | 34.5K | SEC |
| 2024-01-04 | 02-16 | Litton Mark James | CEO | A 獲配股票 | 20.0K | – | – | 149K | SEC |
| 2024-01-04 | 02-16 | Worthington Mark | GENERAL COUNSEL | A 獲配股票 | 10.0K | – | – | 36.9K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 1.9M | 17.1M | 不變 | 持平 |
| Kalehua Capital Management LLC | 787K | 7.2M | 不變 | 持平 |
| ADAR1 Capital Management, LLC | 777K | 7.1M | +49.6K (+7%) | 加碼 |
| ACORN CAPITAL ADVISORS, LLC | 635K | 5.8M | 不變 | 持平 |
| TCG Crossover Management, LLC | 464K | 4.3M | 不變 | 持平 |
| Commodore Capital LP | 464K | 4.3M | 不變 | 持平 |
| NEA Management Company, LLC | 464K | 4.3M | 不變 | 持平 |
| Spruce Street Capital LP | 394K | 3.6M | 不變 | 持平 |
| Blackstone Inc. | 325K | 3.0M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300K | 2.8M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 275K | 2.5M | +80.5K (+41%) | 加碼 |
| Seven Fleet Capital Management LP | 154K | 1.4M | −10.5K (-6%) | 減碼 |
| Propel Bio Management, LLC | 149K | 1.4M | 不變 | 持平 |
| Simplify Asset Management Inc. | 149K | 1.4M | 不變 | 持平 |
| GEODE CAPITAL MANAGEMENT, LLC | 80.4K | 740K | +95 (+0%) | 加碼 |
| BlackRock, Inc. | 79.2K | 728K | +23.1K (+41%) | 加碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 77.4K | 712K | +13.2K (+21%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 42.8K | 393K | +2.8K (+7%) | 加碼 |
| BANK OF AMERICA CORP /DE/ | 32.6K | 299K | −9 (-0%) | 減碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 32.5K | 298K | +772 (+2%) | 加碼 |
| Laird Norton Wetherby Trust Company, LLC | 21.8K | 201K | 不變 | 持平 |
| STATE STREET CORP | 16.3K | 150K | 不變 | 持平 |
| DIMENSIONAL FUND ADVISORS LP | 14.7K | 135K | 新進 | 新進 |
| NORTHERN TRUST CORP | 14.4K | 132K | 不變 | 持平 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 13.3K | 122K | 不變 | 持平 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 44 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 8 / 4 / 7 / 6 |
| 機構合計持股 · 佔流通股 | 7.7M · 81.4% |
| 合計季末市值 | 70.4M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 40.3K |
|---|---|
| 與上期比 | +3.4% |
| 佔流通股數 | 0.43% |
| 日均成交量 | 82.8K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 40.3K | +3.4% | 0.43% | 82.8K | 1.0 |
| 2026-08-14 | 39.0K | -4.3% | 0.41% | 11.1K | 3.5 |
| 2026-07-31 | 40.7K | -24.6% | 0.43% | 20.5K | 2.0 |
| 2026-07-15 | 54.0K | -3.7% | 0.57% | 57.3K | 1.0 |
| 2026-06-30 | 56.1K | +8.6% | 0.60% | 19.0K | 3.0 |
| 2026-06-15 | 51.6K | -8.8% | 0.55% | 17.6K | 2.9 |
| 2026-05-29 | 56.6K | -8.7% | 0.60% | 48.8K | 1.2 |
| 2026-05-15 | 62.0K | +6.8% | 0.66% | 37.4K | 1.7 |
| 2026-04-30 | 58.0K | -26.0% | 0.62% | 37.0K | 1.6 |
| 2026-04-15 | 78.4K | -21.7% | 0.83% | 40.5K | 1.9 |
| 2026-03-31 | 100K | +127.7% | 1.06% | 127K | 1.0 |
| 2026-03-13 | 44.0K | +20.3% | 0.47% | 45.8K | 1.0 |
| 2026-02-27 | 36.6K | +16.9% | 0.39% | 66.5K | 1.0 |
| 2026-02-13 | 31.3K | -9.1% | 0.33% | 38.8K | 1.0 |
| 2026-01-30 | 34.4K | -39.3% | 0.37% | 57.3K | 1.0 |
| 2026-01-15 | 56.7K | -64.6% | 0.60% | 102K | 1.0 |